Fig. 4. The PRE and POST group acceptance rates. PRE includes the 2016-2017 period; POST includes 2019-2020.

Korean J Clin Pharm 2023;33:135-42 https://doi.org/10.24304/kjcp.2023.33.2.135

© 2023 Korean J Clin Pharm